Table 3.
Adjusted estimate (± SE) and p valuea
|
||
---|---|---|
Detectable viral load (≥ 40 copies/ml) (adjusted odds ratio) | Viral load log10 (linear B) | |
Constant | 0.099 (0.101) | 5.081 (0.652) |
0.023* | <30.001*** | |
Intervention (N = 358) | 1.631 (0.662) | 0.191 (0.278) |
0.228 | 0.492 | |
12 month | 0.656 (0.187) | − 0.222 (0.158) |
0.139 | 0.161 | |
24 month | 0.742 (0.236) | 0.147 (0.184) |
0.348 | 0.425 | |
Intervention × 12 month | 0.646 (0.232) | − 0.142 (0.198) |
0.224 | 0.475 | |
Intervention × 24 month | 0.403 (0.147) | − 0.497 (0.199) |
0.013* | 0.013* | |
Group × time χ2 (2) | 6.22 (p = 0.045)* | 6.57 (p = 0.037)* |
Results shown in italics are Chi square omnibus tests of the group-by-time interaction effect
Control N = 344; Intervention N = 358.
p < 0.05,
p < 0.01,
p < 0.001
Adjusted for clinic ID and child ID (random effects) and gender, age, and number of medications (fixed effects)